Cite
HARVARD Citation
Tam, C. et al. (2022). Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre. Internal medicine journal. 52 (7), pp. 1286-1287. [Online].